• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,085.60 -530.80
( -0.68%)
Global Indices
Nasdaq
52,524.20 -133.81
(-0.25%)
Dow Jones
7,536.77 -59.62
(-0.78%)
Hang Seng
67,669.68 426.95
(0.63%)
Nikkei 225
10,494.06 -3.23
(-0.03%)
Forex
USD-INR
95.25 -0.20
(-0.21%)
EUR-INR
108.70 -0.40
(-0.37%)
GBP-INR
127.58 -0.36
(-0.28%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500124
INE089A01031
377.9559391
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DRREDDY
33.65
103049.07
EPS(TTM)
Face Value()
Div & Yield %
36.69
1
0.65
 

Radha Madhav Corporation reports standalone net loss of Rs 0.54 crore in the March 2026 quarter
May 29,2026
Net loss of Radha Madhav Corporation reported to Rs 0.54 crore in the quarter ended March 2026 as against net profit of Rs 0.79 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 as against Rs 0.12 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 0.40 crore in the year ended March 2026 as against net profit of Rs 0.08 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 as against Rs 0.14 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales00.12 -100 00.14 -100
OPM %0-1475.00 -0-1685.71 -
PBDT-0.511.38 PL -0.100.86 PL
PBT-0.540.79 PL -0.400.08 PL
NP-0.540.79 PL -0.400.08 PL